Exicure (XCUR) Assets Average (2017 - 2026)
Exicure (XCUR) reported Assets Average of $13.4 million for Q1 2026, down 25.02% on a YoY basis from $17.9 million in Q1 2025, and down 8.57% quarter-over-quarter from $14.7 million in Q4 2025.
Exicure (XCUR) Assets Average (2017 - 2026) Analysis & Trends
Exicure has reported Assets Average for 10 years, with the latest figure at $13.4 million in Q1 2026.
- For the quarter ending Q1 2026, Assets Average fell 25.02% year-over-year to $13.4 million; the trailing twelve-month figure through Mar 2026 stood at $13.4 million (down 25.02% YoY), and the FY2025 full-year result was $14.5 million, up 9.24% from the prior year.
- Assets Average for Q1 2026 stood at $13.4 million, down from $14.7 million in the prior quarter.
- The five-year high for Assets Average was $53.4 million in Q1 2022, with the low at $10.7 million in Q3 2024.
- Historically, Assets Average has averaged $20.7 million across 5 years, with a median of $17.0 million in 2025.
- Annual changes were most pronounced in 2022 — Assets Average plunged 63.39% — and 2025, when it jumped 84.2%.
- Exicure's Assets Average stood at $26.1 million in 2022, then tumbled by 53.07% to $12.3 million in 2023, then advanced by 4.72% to $12.8 million in 2024, then rose by 14.1% to $14.7 million in 2025, then slipped by 8.57% to $13.4 million in 2026.
- The last three Assets Average figures came in at $13.4 million (Q1 2026), $14.7 million (Q4 2025), and $17.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | 33.42 Mn |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | 795.91 Mn |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | 13.04 Mn |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | 1.72 Bn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | 40.89 Mn |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | 26.03 Mn |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | 10.06 Mn |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 26.06 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | 660.38 Mn |
| 10 | Exicure | 19.38 Mn | 16.77 Mn | - | 13.40 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 13.40 Mn |
| Dec 31, 2025 | 14.65 Mn |
| Sep 30, 2025 | 17.00 Mn |
| Jun 30, 2025 | 19.71 Mn |
| Mar 31, 2025 | 17.87 Mn |
| Dec 31, 2024 | 12.84 Mn |
| Sep 30, 2024 | 10.66 Mn |
| Jun 30, 2024 | 10.70 Mn |
| Mar 31, 2024 | 11.15 Mn |
| Dec 31, 2023 | 12.27 Mn |
| Sep 30, 2023 | 15.25 Mn |
| Jun 30, 2023 | 20.75 Mn |
| Mar 31, 2023 | 23.64 Mn |
| Dec 31, 2022 | 26.14 Mn |
| Sep 30, 2022 | 32.95 Mn |
| Jun 30, 2022 | 39.43 Mn |
| Mar 31, 2022 | 53.38 Mn |
| Dec 31, 2021 | 71.38 Mn |
| Sep 30, 2021 | 76.18 Mn |
| Jun 30, 2021 | 81.21 Mn |